Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1293458.RAgmWZqZMslx5jERRcomvlLWY7VP669sEcU8vH2_KEirw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1293458.RAgmWZqZMslx5jERRcomvlLWY7VP669sEcU8vH2_KEirw130_assertion type Assertion NP1293458.RAgmWZqZMslx5jERRcomvlLWY7VP669sEcU8vH2_KEirw130_head.
- NP1293458.RAgmWZqZMslx5jERRcomvlLWY7VP669sEcU8vH2_KEirw130_assertion description "[Inhibition of BCR-ABL and RIN1 interaction using exogenous modified BCR-ABL SH3 domain provides a feasible and alternative option of small molecule inhibitors for CML treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1293458.RAgmWZqZMslx5jERRcomvlLWY7VP669sEcU8vH2_KEirw130_provenance.
- NP1293458.RAgmWZqZMslx5jERRcomvlLWY7VP669sEcU8vH2_KEirw130_assertion evidence source_evidence_literature NP1293458.RAgmWZqZMslx5jERRcomvlLWY7VP669sEcU8vH2_KEirw130_provenance.
- NP1293458.RAgmWZqZMslx5jERRcomvlLWY7VP669sEcU8vH2_KEirw130_assertion SIO_000772 26321052 NP1293458.RAgmWZqZMslx5jERRcomvlLWY7VP669sEcU8vH2_KEirw130_provenance.
- NP1293458.RAgmWZqZMslx5jERRcomvlLWY7VP669sEcU8vH2_KEirw130_assertion wasDerivedFrom befree-2016 NP1293458.RAgmWZqZMslx5jERRcomvlLWY7VP669sEcU8vH2_KEirw130_provenance.
- NP1293458.RAgmWZqZMslx5jERRcomvlLWY7VP669sEcU8vH2_KEirw130_assertion wasGeneratedBy ECO_0000203 NP1293458.RAgmWZqZMslx5jERRcomvlLWY7VP669sEcU8vH2_KEirw130_provenance.